December 15, 2025 11:00 AM ET Information blocking continues to hinder timely access to electronic health data for patients, providers, payers, and the federal government. While federal regulations prohibit interference with data exchange, in practice key participants across the health data landscape continue to limit access in ways that constrain care delivery, population health efforts, … Continue reading
December 17, 2025 1:00 PM ET Join HMA and the National Alliance for Impacting the Social Determinants of Health (NASDOH), an alliance managed by Leavitt Partners, an HMA Company, for an in-depth discussion on the evolving policy landscape on the upstream drivers of health, which includes the social, economic, and environmental conditions that influence whether … Continue reading
Today, Leavitt Partners released a Medicare policy guide that provides an accessible overview of several major policy concepts that have circulated in Medicare reform conversations in recent years. With debate mounting over the future of Medicare, it is imperative that policymakers first understand these core policy proposals–including site neutral payments, competitive bidding in Medicare Advantage, … Continue reading
Information blocking continues to hinder timely access to electronic health data for patients, providers, payers, and the federal government. While federal regulations prohibit interference with data exchange, in practice information blocking remains largely unchecked. Because of insufficient enforcement of these regulations, data continue to be delayed or withheld from patients, clinicians, payers, and networks–resulting in … Continue reading
Leavitt Partners, an HMA Company, is pleased to announce that Elaine Lippmann, J.D., has joined the firm as a principal, located in Washington, D.C. Lippmann joins recently hired former U.S. Food and Drug Administration (FDA) leader Julie Tierney on an expert team of health policy and government affairs consultants at Leavitt Partners. Collectively, our bipartisan … Continue reading
THE CURRENT ENVIRONMENT Life science organizations and other stakeholders impacted by the U.S. Food and Drug Administration (FDA) face exciting opportunities and demanding challenges, operating at the nexus of cutting-edge science, patient needs, and evolving regulatory requirements while facing political and regulatory scrutiny. Novel therapies, including those created through advancements in cell and gene therapies, … Continue reading
Leavitt Partners, an HMA Company, is pleased to announce that Julie Tierney has joined the company’s team of health policy experts as a principal, located in Washington, D.C. Tierney is a proven executive with more than 20 years of FDA legal, policy, and operational experience. She held a number of senior roles at FDA, including … Continue reading
This webinar was held on Friday, August 8, 2025. This webinar examined two recent developments with the potential to reshape healthcare data exchange: the release of the Kill the Clipboard policy roadmap and the White House and CMS announcement of what they envision as a CMS-aligned network. While the past decade has brought significant policy … Continue reading
This webinar was held on June 23, 2025. In March 2025, Leavitt Partners, an HMA Company, in conjunction with a number of multi-sector stakeholders, released Kill the Clipboard! A Federal Policy and Industry Roadmap to Accelerate Innovation and Cut Administrative Waste. Just three months later, the U.S. Department of Health and Human Services released its Request for … Continue reading
A recent survey conducted by WEDI, a national association for health IT guidance and collaboration, underscores significant delays among both providers and health plans in preparing for The Centers for Medicare & Medicaid Services (CMS)’s Interoperability and Prior Authorization Final Rule (CMS-0057-F). The rule introduces new requirements-including Fast Healthcare Interoperability Resources (FHIR) implementation and prior authorization … Continue reading
